FDA Drug Recalls

Recalls / Class III

Class IIID-0198-2025

Product

Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E., Suite 117, Fairfield, NJ 07004, NDC 71399-8028-2.

Affected lot / code info
Lot: KDC0124002B Exp 09/30/2026

Why it was recalled

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Recalling firm

Firm
Akron Pharma, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
373 Us Highway 46 Ste 117, Fairfield, New Jersey 07004-2456

Distribution

Quantity
456 bottles
Distribution pattern
Nationwide in the US

Timeline

Recall initiated
2024-12-12
FDA classified
2025-01-10
Posted by FDA
2025-01-22
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0198-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.